Internal Medicine: Special Topics and Prevention

Internal Medicine: Special Topics and Prevention — Expert Guide

How it begins

Riesgo cardiovascular, tamizaje oncológico, enfermedades metabólicas, tópicos especiales del adulto y medicina basada en la evidencia preventiva

What it covers

1. Principles of Prevention in Internal Medicine
2. · The Four Pillars of Cardiovascular Prevention (ESC 2021)
3. Global Cardiovascular Risk Assessment
4. · Risk Estimation Models
5. · Non-Traditional Risk Markers
6. Dyslipidemia and Hypolipidemic Treatment
7. · LDL-C Goals According to CV Risk (ESC 2019/2021)
8. · Statins: The Pillar of Treatment
9. · Beyond Statins: Ezetimibe, i-PCSK9, Bempedoic, Inclisirán
10. Systemic Arterial Hypertension
11. · Classification and Diagnosis
12. · Pharmacological Treatment: Combination Strategy
13. · Hypertensive Emergencies and Emergencies
14. Diabetes Mellitus Type 2: Prevention and Treatment
15. · Prevention and Diagnosis of DM2
16. · Modern Pharmacological Treatment of DM2
17. · Chronic Complications of DM2
18. Metabolic Syndrome, Obesity and MAFLD
19. · Metabolic Syndrome: Diagnosis and Relevance
20. · Obesity: Medical and Surgical Treatment
21. · Metabolic Fatty Liver Disease (MAFLD / MASH)
22. Smoking and Cessation Strategies
23. Oncological Screening
24. · Colorectal Cancer (CRC): The Most Effective Screening
25. · Breast Cancer
26. · Cervical Cancer
27. · Lung Cancer: Low Dose CT (LDCT)
28. · Prostate Cancer: PSA and Its Controversies
29. Adult Vaccination
30. Osteoporosis and Bone Health
31. Chronic Kidney Disease: Prevention and Management
32. Hyperuricemia and Gout
33. Obstructive Sleep Apnea Syndrome (OSA)
34. Frailty and Sarcopenia
35. Polypharmacy in the Elderly: Deprescription
36. Key Nutritional Deficiencies
37. · Vitamin D
38. · Iron deficiency and Iron deficiency anemia
39. · Vitamin B12 (Cobalamin)
40. Alcohol and Health: Risk, Organ Damage and Treatment
41. Antiaggregation and Preventive Anticoagulation
42. · Aspirin in Cardiovascular Prevention: The Great Paradigm Shift
43. · Double Antiaggregation (DAPT) and Anticoagulation in Specific Contexts